UnitedHealth Group (NYSE:UNH) Research Coverage Started at Edward Jones

Edward Jones initiated coverage on shares of UnitedHealth Group (NYSE:UNH) in a research report report published on Monday, The Fly reports. The brokerage issued a buy rating on the healthcare conglomerate’s stock.

Several other research firms have also recently weighed in on UNH. Royal Bank of Canada boosted their price target on shares of UnitedHealth Group from $476.00 to $512.00 and gave the stock an outperform rating in a report on Wednesday, December 1st. BMO Capital Markets boosted their price target on shares of UnitedHealth Group from $475.00 to $500.00 and gave the stock a market perform rating in a report on Thursday, December 2nd. They noted that the move was a valuation call. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $499.00 to $526.00 and gave the stock an overweight rating in a report on Wednesday, December 1st. Zacks Investment Research upgraded shares of UnitedHealth Group from a hold rating to a buy rating and set a $477.00 price target on the stock in a report on Wednesday, October 27th. Finally, UBS Group boosted their target price on shares of UnitedHealth Group from $435.00 to $452.00 and gave the company a neutral rating in a research note on Wednesday, December 1st. They noted that the move was a valuation call. Two investment analysts have rated the stock with a hold rating, twenty-two have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of Buy and a consensus price target of $500.54.

NYSE:UNH opened at $473.72 on Monday. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.77 and a quick ratio of 0.77. The firm has a 50-day moving average of $469.31 and a 200-day moving average of $435.22. The company has a market cap of $446.17 billion, a PE ratio of 29.09, a PEG ratio of 1.86 and a beta of 0.86. UnitedHealth Group has a one year low of $320.35 and a one year high of $509.23.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 EPS for the quarter, topping the consensus estimate of $4.41 by $0.11. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The company had revenue of $72.34 billion during the quarter, compared to the consensus estimate of $71.24 billion. During the same period in the previous year, the firm posted $3.51 earnings per share. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group will post 18.84 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 14th. Stockholders of record on Monday, December 6th were issued a $1.45 dividend. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.22%. The ex-dividend date of this dividend was Friday, December 3rd. UnitedHealth Group’s payout ratio is 35.98%.

In other news, Director Stephen J. Hemsley sold 75,000 shares of the company’s stock in a transaction on Monday, October 25th. The shares were sold at an average price of $448.72, for a total value of $33,654,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction on Tuesday, November 23rd. The shares were sold at an average price of $444.70, for a total transaction of $1,111,750.00. The disclosure for this sale can be found here. 0.55% of the stock is owned by corporate insiders.

Several institutional investors have recently made changes to their positions in the company. Harbour Capital Advisors LLC boosted its position in UnitedHealth Group by 1.9% during the 4th quarter. Harbour Capital Advisors LLC now owns 15,905 shares of the healthcare conglomerate’s stock valued at $7,987,000 after buying an additional 297 shares during the period. First Hawaiian Bank boosted its position in UnitedHealth Group by 37.1% during the 4th quarter. First Hawaiian Bank now owns 20,353 shares of the healthcare conglomerate’s stock valued at $10,220,000 after buying an additional 5,503 shares during the period. Winthrop Advisory Group LLC boosted its position in UnitedHealth Group by 17.6% during the 4th quarter. Winthrop Advisory Group LLC now owns 937 shares of the healthcare conglomerate’s stock valued at $471,000 after buying an additional 140 shares during the period. Contravisory Investment Management Inc. boosted its position in UnitedHealth Group by 1.0% during the 4th quarter. Contravisory Investment Management Inc. now owns 18,649 shares of the healthcare conglomerate’s stock valued at $9,364,000 after buying an additional 176 shares during the period. Finally, Pure Financial Advisors LLC lifted its position in shares of UnitedHealth Group by 7.4% in the 4th quarter. Pure Financial Advisors LLC now owns 2,209 shares of the healthcare conglomerate’s stock worth $1,109,000 after purchasing an additional 152 shares during the period. 86.20% of the stock is owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Featured Article: Range Trading

The Fly logo

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.